日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy

卡非佐米诱导的血栓性微血管病多发性骨髓瘤患者的替代补体途径突变

Moscvin, Maria; Liacos, Christine Ivy; Chen, Tianzeng; Theodorakakou, Foteini; Fotiou, Despina; Hossain, Shahrier; Rowell, Sean; Leblebjian, Houry; Regan, Eileen; Czarnecki, Peter; Bagnoli, Filippo; Bolli, Niccolo'; Richardson, Paul; Rennke, Helmut G; Dimopoulos, Meletios A; Kastritis, Efstathios; Bianchi, Giada

Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma.

靶向 LAG3/GAL-3 以克服免疫抑制并增强多发性骨髓瘤的抗肿瘤免疫反应

Bae Jooeun, Accardi Fabrizio, Hideshima Teru, Tai Yu-Tzu, Prabhala Rao, Shambley Aaron, Wen Kenneth, Rowell Sean, Richardson Paul G, Munshi Nikhil C, Anderson Kenneth C